Matthew K Fust Insider Trading $JAZZ Jazz Pharmaceuticals plc
Get free email notifications about insider trading for Matthew K Fust.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Matthew K Fust. Matthew K Fust is EVP and CFO in Jazz Pharmaceuticals plc ($JAZZ) and EVP, Chief Financial Officer in Jazz Pharmaceuticals plc ($JAZZ) and Senior Vice President & CFO in Jazz Pharmaceuticals plc ($JAZZ) and SVP and CFO in Jazz Pharmaceuticals plc ($JAZZ) and Director in MACROGENICS INC ($MGNX) and in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Ultragenyx Pharmaceutical Inc. ($RARE) and in Dermira, Inc. ($DERM) and Director in Dermira, Inc. ($DERM) and Director in Atara Biotherapeutics, Inc. ($ATRA) and Director in Crinetics Pharmaceuticals, Inc. ($CRNX).
Matthew K Fust in Jazz Pharmaceuticals plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew K Fust: EVP, Chief Financial Officer, EVP and CFO, SVP and CFO, Senior Vice President & CFO
Holdings: 58,948 shares
Current Value: $7,371,447
Latest Transaction: Dec 01 2008
$JAZZ Market Capitalization: $7.62B
$JAZZ Previous Close: $125.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Matthew K Fust in Jazz Pharmaceuticals plc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ATRA, CRNX, DERM, JAZZ, MGNX, RARE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 01 2008 | JAZZ | Jazz Pharmaceutica ... | Fust Matthew K | EVP, Chief Financia ... | Buy | J | 1.28 | 379 | 485 | 58,948 | 58.6 K to 58.9 K (+0.65 %) |
| Jun 02 2008 | JAZZ | Jazz Pharmaceutica ... | Fust Matthew K | EVP and CFO | Buy | J | 6.50 | 1,203 | 7,820 | 58,569 | 57.4 K to 58.6 K (+2.10 %) |
| May 19 2008 | JAZZ | Jazz Pharmaceutica ... | Fust Matthew K | EVP and CFO | Option Exercise | A | 7.96 | 60,000 | 477,600 | 60,000 | |
| May 19 2008 | JAZZ | Jazz Pharmaceutica ... | Fust Matthew K | EVP and CFO | Grant | A | 0.00 | 6,281 | 0 | 57,366 | 51.1 K to 57.4 K (+12.30 %) |
| Dec 03 2007 | JAZZ | Jazz Pharmaceutica ... | Fust Matthew K | SVP and CFO | Buy | J | 13.18 | 1,388 | 18,294 | 51,085 | 49.7 K to 51.1 K (+2.79 %) |
| Jun 06 2007 | JAZZ | Jazz Pharmaceutica ... | Fust Matthew K | Senior Vice Preside ... | Option Exercise | C | 0.00 | 19,879 | 0 | 0 | |
| Jun 06 2007 | JAZZ | Jazz Pharmaceutica ... | Fust Matthew K | Senior Vice Preside ... | Buy | C | 0.00 | 19,879 | 0 | 49,697 | 29.8 K to 49.7 K (+66.67 %) |
Page: 1